Oxidative stress and DNA methylation regulation in the metabolic syndrome

Epigenomics

Volumn 7, Issue 2, 2015, Pages 283-300

  Yara, Sabrina ^a   Lavoie, Jean Claude ^a,b   Levy, Emile ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

antioxidant defense; DNA methylation; fetal programming; inflammation; metabolic syndrome; nutrition; oxidative stress

Indexed keywords

DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; GENOME IMPRINTING; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NONHUMAN; NUTRITION; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TISSUE SPECIFICITY; DIABETES MELLITUS, TYPE 2; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM;

DIABETES MELLITUS, TYPE 2; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY; OXIDATIVE STRESS;

EID: 84928896809     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.14.84     Document Type: Review

References (151)

1. Holliday R. The inheritance of epigenetic defects. Science 238(4824), 163-170 (1987).
2. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16(1), 6-21 (2002).
3. Ehrlich M, Gama-Sosa MA, Huang LH et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 10(8), 2709-2721 (1982).
4. Larsen F, Gundersen G, Lopez R, Prydz H. CpG islands as gene markers in the human genome. Genomics 13(4), 1095-1107 (1992).
5. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 293(5532), 1068-1070 (2001).
6. Bestor TH, Gundersen G, Kolsto AB, Prydz H. CpG islands in mammalian gene promoters are inherently resistant to de novo methylation. Genet. Anal. Tech. Appl. 9(2), 48-53 (1992).
7. Pradhan S, Bacolla A, Wells RD, Roberts RJ. Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. 274(46), 33002-33010 (1999).
8. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 366(6453), 362-365 (1993).
9. Beard C, Li E, Jaenisch R. Loss of methylation activates Xist in somatic but not in embryonic cells. Genes Dev. 9(19), 2325-2334 (1995).
10. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19(3), 219-220 (1998).
11. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247-257 (1999).
12. Hsieh CL. In vivo activity of murine de novo methyltransferases, Dnmt3a and Dnmt3b. Mol. Cell Biol. 19(12), 8211-8218 (1999).
13. Bestor TH. The DNA methyltransferases of mammals. Hum. Mol. Genet. 9(16), 2395-2402 (2000).
14. Morgan HD, Santos F, Green K, Dean W, Reik W. Epigenetic reprogramming in mammals. Hum. Mol. Genet. 14 Spec No 1, R47-R58 (2005).
15. Fatemi M, Hermann A, Gowher H, Jeltsch A. Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur. J. Biochem. 269(20), 4981-4984 (2002).
16. Kim GD, Ni J, Kelesoglu N, Roberts RJ, Pradhan S. Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J. 21(15), 4183-4195 (2002).
17. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405(6785), 486-489 (2000).
18. Loenen WA. S-adenosylmethionine: jack of all trades and master of everything? Biochem. Soc. Trans. 34(Pt 2), 330-333 (2006).
19. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell Biol. 18(11), 6538-6547 (1998).
20. Nan X, Meehan RR, Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 21(21), 4886-4892 (1993).
21. Boyes J, Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J. 11(1), 327-333 (1992).
22. Hsieh CL. Dependence of transcriptional repression on CpG methylation density. Mol. Cell Biol. 14(8), 5487-5494 (1994).
23. Kass SU, Landsberger N, Wolffe AP. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7(3), 157-165 (1997).
24. Mohandas T, Sparkes RS, Shapiro LJ. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211(4480), 393-396 (1981).
25. Graves JA. 5-azacytidine-induced re-expression of alleles on the inactive X chromosome in a hybrid mouse cell line. Exp. Cell Res. 141(1), 99-105 (1982).
26. Venolia L, Gartler SM, Wassman ER, Yen P, Mohandas T, Shapiro LJ. Transformation with DNA from 5-azacytidinereactivated X chromosomes. Proc. Natl Acad. Sci. USA 79(7), 2352-2354 (1982).
27. Jaenisch R, Schnieke A, Harbers K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc. Natl Acad. Sci. USA 82(5), 1451-1455 (1985).
28. Sado T, Fenner MH, Tan SS, Tam P, Shioda T, Li E. X inactivation in the mouse embryo deficient for Dnmt1: distinct effect of hypomethylation on imprinted and random X inactivation. Dev. Biol. 225(2), 294-303 (2000).
29. Barros SP, Offenbacher S. Epigenetics: connecting environment and genotype to phenotype and disease. J. Dent. Res. 88(5), 400-408 (2009).
30. Miranda TB, Jones PA. DNA methylation: the nuts and bolts of repression. J. Cell Physiol. 213(2), 384-390 (2007).
31. Arnaud P, Feil R. Epigenetic deregulation of genomic imprinting in human disorders and following assisted reproduction. Birth Defects Res. C. Embryo. Today 75(2), 81-97 (2005).
32. Tobi EW, Lumey LH, Talens RP et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet. 18(21), 4046-4053 (2009).
33. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br. Med. Bull. 60, 5-20 (2001).
34. Morgan HD, Sutherland HG, Martin DI, Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 23(3), 314-318 (1999).
35. Waterland RA. Do maternal methyl supplements in mice affect DNA methylation of offspring? J. Nutr. 133(1), 238 (2003).
36. Waterland RA. Assessing the effects of high methionine intake on DNA methylation. J. Nutr. 136(6 Suppl.), S1706-S1710 (2006).
37. Waterland RA, Dolinoy DC, Lin JR, Smith CA, Shi X, Tahiliani KG. Maternal methyl supplements increase offspring DNA methylation at axin fused. Genesis 44(9), 401-406 (2006).
38. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr. 132(8 Suppl.), S2393-S2400 (2002).
39. Burdge GC, Slater-Jefferies J, Torrens C, Phillips ES, Hanson MA, Lillycrop KA. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br. J. Nutr. 97(3), 435-439 (2007).
40. Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr. 135(6), 1382-1386 (2005).
41. Lillycrop KA, Slater-Jefferies JL, Hanson MA, Godfrey KM, Jackson AA, Burdge GC. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br. J. Nutr. 97(6), 1064-1073 (2007).
42. Burdge GC, Lillycrop KA, Phillips ES, Slater-Jefferies JL, Jackson AA, Hanson MA. Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J. Nutr. 139(6), 1054-1060 (2009).
43. Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ. Res. 100(4), 520-526 (2007).
44. Van Straten EM, Bloks VW, Huijkman NC et al. The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298(2), R275-R282 (2010).
45. Sinclair KD, Allegrucci C, Singh R et al. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status. Proc. Natl Acad. Sci. USA 104(49), 19351-19356 (2007).
46. Torrens C, Brawley L, Anthony FW et al. Folate supplementation during pregnancy improves offspring cardiovascular dysfunction induced by protein restriction. Hypertension 47(5), 982-987 (2006).
47. Plagemann A, Harder T, Brunn M et al. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J. Physiol. 587(Pt 20), 4963-4976 (2009).
48. Godfrey KM, Redman CW, Barker DJ, Osmond C. The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight. Br. J. Obstet. Gynaecol. 98(9), 886-891 (1991).
49. Gambling L, Dunford S, Wallace DI et al. Iron deficiency during pregnancy affects postnatal blood pressure in the rat. J. Physiol 552(Pt 2), 603-610 (2003).
50. Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet JJ. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 40(Suppl. 2), 115-120 (1991).
51. Blondeau B, Avril I, Duchene B, Breant B. Endocrine pancreas development is altered in foetuses from rats previously showing intra-uterine growth retardation in response to malnutrition. Diabetologia 45(3), 394-401 (2002).
52. Hales CN, Barker DJ, Clark PM et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303(6809), 1019-1022 (1991).
53. Montague CT, Farooqi IS, Whitehead JP et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387(6636), 903-908 (1997).
54. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20(2), 113-114 (1998).
55. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, Orahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20(2), 111-112 (1998).
56. Large V, Reynisdottir S, Eleborg L, Van Harmelen V, Strommer L, Arner P. Lipolysis in human fat cells obtained under local and general anesthesia. Int. J. Obes. Relat Metab Disord. 21(1), 78-82 (1997).
57. Klannemark M, Orho M, Langin D et al. The putative role of the hormone-sensitive lipase gene in the pathogenesis of Type II diabetes mellitus and abdominal obesity. Diabetologia 41(12), 1516-1522 (1998).
58. Clement K, Ruiz J, Cassard-Doulcier AM et al. Additive effect of A->G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int. J. Obes. Relat Metab Disord. 20(12), 1062-1066 (1996).
59. Maddux BA, Sbraccia P, Kumakura S et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulindependent diabetes mellitus. Nature 373(6513), 448-451 (1995).
60. Ristow M, Muller-Wieland D, Pfeiffer A, Krone W, Kahn CR. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med. 339(14), 953-959 (1998).
61. Clausen JO, Hansen T, Bjorbaek C et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346(8972), 397-402 (1995).
62. Kiskinis E, Hallberg M, Christian M et al. RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytes. EMBO J. 26(23), 4831-4840 (2007).
63. Milagro FI, Campion J, Garcia-Diaz DF, Goyenechea E, Paternain L, Martinez JA. High fat diet-induced obesity modifies the methylation pattern of leptin promoter in rats. J. Physiol. Biochem. 65(1), 1-9 (2009).
64. Campion J, Milagro FI, Goyenechea E, Martinez JA. TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver. Spring) 17(6), 1293-1297 (2009).
65. Park JH, Stoffers DA, Nicholls RD, Simmons RA. Development of Type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest. 118(6), 2316-2324 (2008).
66. Ling C, Del GS, Lupi R et al. Epigenetic regulation of PPARGC1A in human Type 2 diabetic islets and effect on insulin secretion. Diabetologia 51(4), 615-622 (2008).
67. Barres R, Osler ME, Yan J et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 10(3), 189-198 (2009).
68. Lomba A, Milagro FI, Garcia-Diaz DF, Marti A, Campion J, Martinez JA. Obesity induced by a pair-fed high fat sucrose diet: methylation and expression pattern of genes related to energy homeostasis. Lipids Health Dis. 9, 60 (2010).
69. Einstein F, Thompson RF, Bhagat TD et al. Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS ONE 5(1), e8887 (2010).
70. Lee HA, Lee DY, Lee HJ, Han HS, Kim I. Enrichment of (pro)renin receptor promoter with activating histone codes in the kidneys of spontaneously hypertensive rats. J. Renin. Angiotensin. Aldosterone. Syst. 13(1), 11-18 (2011).
71. Jiang Q, Yuan H, Xing X, Liu J, Huang Z, Du X. Methylation of adrenergic beta1 receptor is a potential epigenetic mechanism controlling antihypertensive response to metoprolol. Indian J. Biochem. Biophys. 48(5), 301-307 (2011).
72. Cho HM, Lee HA, Kim HY, Han HS, Kim IK. Expression of Na+-K+ -2Cl- cotransporter 1 is epigenetically regulated during postnatal development of hypertension. Am. J. Hypertens. 24(12), 1286-1293 (2011).
73. Chelbi ST, Mondon F, Jammes H et al. Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension 49(1), 76-83 (2007).
74. Goyal R, Goyal D, Leitzke A, Gheorghe CP, Longo LD. Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod. Sci. 17(3), 227-238 (2010).
75. Lu Z, Xu X, Hu X et al. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid. Redox. Signal. 13(7), 1011-1022 (2010).
76. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol. Rev. 78(2), 547-581 (1998).
77. Buettner GR, Ng CF, Wang M, Rodgers VG, Schafer FQ. A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic. Biol. Med. 41(8), 1338-1350 (2006).
78. Jones P, Suggett A. The catalse-hydrogen peroxide system. Kinetics of catalatic action at high substrate concentrations. Biochem. J. 110(4), 617-620 (1968).
79. Gaetani GF, Ferraris AM, Rolfo M, Mangerini R, Arena S, Kirkman HN. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 87(4), 1595-1599 (1996).
80. Flohe L, Brand I. Kinetics of glutathione peroxidase. Biochim. Biophys. Acta 191(3), 541-549 (1969).
81. Fazeli G, Stopper H, Schinzel R, Ni CW, Jo H, Schupp N. Angiotensin II induces DNA damage via AT1 receptor and NADPH oxidase isoform Nox4. Mutagenesis, 27(6), 673-681 (2012).
82. Davel AP, Ceravolo GS, Wenceslau CF, Carvalho MH, Brum PC, Rossoni LV. Increased vascular contractility and oxidative stress in beta(2)-adrenoceptor knockout mice: the role of NADPH oxidase. J. Vasc. Res. 49(4), 342-352 (2012).
83. Zielinska-Przyjemska M, Olejnik A, Dobrowolska-Zachwieja A, Grajek W. In vitro effects of beetroot juice and chips on oxidative metabolism and apoptosis in neutrophils from obese individuals. Phytother. Res. 23(1), 49-55 (2009).
84. Morgan D, Rebelato E, Abdulkader F et al. Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells. Endocrinology 150(5), 2197-2201 (2009).
85. Finkel T. Oxygen radicals and signaling. Curr. Opin. Cell Biol. 10(2), 248-253 (1998).
86. Haase H, Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 18(4), 333-338 (2005).
87. Rhee SG, Bae YS, Lee SR, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE 2000(53), e1 (2000).
88. Jones DP. Radical-free biology of oxidative stress. Am. J. Physiol Cell Physiol 295(4), C849-C868 (2008).
89. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/ glutathione couple. Free Radic. Biol. Med. 30(11), 1191-1212 (2001).
90. Skalicky J, Muzakova V, Kandar R, Meloun M, Rousar T, Palicka V. Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome. Clin. Chem. Lab Med. 46(4), 499-505 (2008).
91. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am. J. Physiol 277(6 Pt 1), E971-E975 (1999).
92. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38(2-3), 189-197 (2001).
93. Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). Int. J. Mol. Med. 4(3), 223-230 (1999).
94. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114(12), 1752-1761 (2004).
95. Tian YF, Hsia TL, Hsieh CH, Huang DW, Chen CH, Hsieh PS. The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in highfat- fed rats. Life Sci. 89(3-4), 107-114 (2011).
96. Darchivio M, Annuzzi G, Vari R et al. Predominant role of obesity/insulin resistance in oxidative stress development. Eur. J. Clin. Invest 42(1), 70-78 (2012).
97. Codoner-Franch P, Tavarez-Alonso S, Murria-Estal R, Herrera-Martin G, Alonso-Iglesias E. Polyamines are increased in obese children and are related to markers of oxidative/nitrosative stress and angiogenesis. J. Clin. Endocrinol. Metab 96(9), 2821-2825 (2011).
98. Stancliffe RA, Thorpe T, Zemel MB. Dairy attentuates oxidative and inflammatory stress in metabolic syndrome. Am. J. Clin. Nutr. 94(2), 422-430 (2011).
99. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96(1), 25-28 (1997).
100. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 13(1), 23-30 (1999).
101. Matsunami T, Sato Y, Sato T, Yukawa M. Antioxidant status and lipid peroxidation in diabetic rats under hyperbaric oxygen exposure. Physiol Res. 59(1), 97-104 (2010).
102. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Radic. Biol. Med. 25(3), 369-372 (1998).
103. Davi G, Ciabattoni G, Consoli A et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99(2), 224-229 (1999).
104. Chao PC, Huang CN, Hsu CC, Yin MC, Guo YR. Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1alpha and MCP-1 levels in Type 2 diabetic patients. Eur. J. Nutr. 49(7), 429-434 (2010).
105. Rabbani N, Chittari MV, Bodmer CW, Zehnder D, Ceriello A, Thornalley PJ. Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with Type 2 diabetes and effect of metformin. Diabetes 59(4), 1038-1045 (2010).
106. Vericel E, Januel C, Carreras M, Moulin P, Lagarde M. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes 53(4), 1046-1051 (2004).
107. Chabrashvili T, Tojo A, Onozato ML et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39(2), 269-274 (2002).
108. Lassegue B, Griendling KK. Reactive oxygen species in hypertension; an update. Am. J. Hypertens. 17(9), 852-860 (2004).
109. Weber DS, Rocic P, Mellis AM et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am. J. Physiol Heart Circ. Physiol 288(1), H37-H42 (2005).
110. Fukui T, Ishizaka N, Rajagopalan S et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80(1), 45-51 (1997).
111. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest 97(8), 1916-1923 (1996).
112. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95(3), 588-593 (1997).
113. Kitiyakara C, Chabrashvili T, Chen Y et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J. Am. Soc. Nephrol. 14(11), 2775-2782 (2003).
114. Kitiyakara C, Wilcox CS. Antioxidants for hypertension. Curr. Opin. Nephrol. Hypertens. 7(5), 531-538 (1998).
115. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr. Opin. Nephrol. Hypertens. 10(2), 247-255 (2001).
116. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res. 55(2), 239-249 (2002).
117. Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108(17), 2034-2040 (2003).
118. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86(5), 494-501 (2000).
119. Wang HQ, Smart RC. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. J. Cell Sci. 112(Pt 20), 3497-3506 (1999).
120. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV- 1. EMBO J. 10(8), 2247-2258 (1991).
121. Portugal M, Barak V, Ginsburg I, Kohen R. Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations. Biomed. Pharmacother. 61(7), 412-422 (2007).
122. Hart CM, Karman RJ, Blackburn TL, Gupta MP, Garcia JG, Mohler ER, Iii. Role of 8-epi PGF2alpha, 8-isoprostane, in H2O2-induced derangements of pulmonary artery endothelial cell barrier function. Prostaglandins Leukot. Essent. Fatty Acids 58(1), 9-16 (1998).
123. Hayes P, Knaus UG. Balancing reactive oxygen species in the epigenome: NADPH oxidases as target and perpetrator. Antioxid. Redox. Signal. 18(15), 1937-1945 (2013).
124. Campos AC, Molognoni F, Melo FH et al. Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. Neoplasia. 9(12), 1111-1121 (2007).
125. Hitchler MJ, Domann FE. An epigenetic perspective on the free radical theory of development. Free Radic. Biol. Med. 43(7), 1023-1036 (2007).
126. Afanasev I. New nucleophilic mechanisms of ros-dependent epigenetic modifications: comparison of aging and cancer. Aging Dis. 5(1), 52-62 (2014).
127. Xiong F, Xiao D, Zhang L. Norepinephrine causes epigenetic repression of PKCepsilon gene in rodent hearts by activating Nox1-dependent reactive oxygen species production. FASEB J. 26(7), 2753-2763 (2012).
128. Nanduri J, Makarenko V, Reddy VD et al. Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis. Proc. Natl Acad. Sci. USA 109(7), 2515-2520 (2012).
129. Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A, Boonla C. Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line. Asian Pac. J. Cancer Prev. 14(6), 3773-3778 (2013).
130. Zhang R, Kang KA, Kim KC et al. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells. Gene 524(2), 214-219 (2013).
131. Cyr AR, Hitchler MJ, Domann FE. Regulation of SOD2 in cancer by histone modifications and CpG methylation: closing the loop between redox biology and epigenetics. Antioxid. Redox. Signal. 18(15), 1946-1955 (2013).
132. Archer SL, Marsboom G, Kim GH et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 121(24), 2661-2671 (2010).
133. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20(1), 85-93 (1980).
134. Patel K, Dickson J, Din S, Macleod K, Jodrell D, Ramsahoye B. Targeting of 5-aza-2-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme. Nucleic Acids Res. 38(13), 4313-4324 (2010).
135. Kim HJ, Kim JH, Chie EK, Young PD, Kim IA, Kim IH. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Radiat. Oncol. 7, 39 (2012).
136. Hodge DR, Peng B, Pompeia C et al. Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol. Ther. 4(5), 585-592 (2005).
137. Kamiya T, Machiura M, Makino J, Hara H, Hozumi I, Adachi T. Epigenetic regulation of extracellular-superoxide dismutase in human monocytes. Free Radic. Biol. Med. 61, 197-205 (2013).
138. Zelko IN, Mueller MR, Folz RJ. CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression. Free Radic. Biol. Med. 48(7), 895-904 (2010).
139. Chen B, Rao X, House MG, Nephew KP, Cullen KJ, Guo Z. GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer Lett. 309(1), 37-45 (2011).
140. Hahn MA, Hahn T, Lee DH et al. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 68(24), 10280-10289 (2008).
141. Lee OJ, Schneider-Stock R, Mcchesney PA et al. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barretts tumorigenesis. Neoplasia. 7(9), 854-861 (2005).
142. Peng DF, Razvi M, Chen H et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barretts adenocarcinoma. Gut 58(1), 5-15 (2009).
143. Khor TO, Huang Y, Wu TY, Shu L, Lee J, Kong AN. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem. Pharmacol. 82(9), 1073-1078 (2011).
144. Min JY, Lim SO, Jung G. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett. 584(11), 2427-2432 (2010).
145. Karius T, Schnekenburger M, Ghelfi J, Walter J, Dicato M, Diederich M. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines. Biochem. Pharmacol. 81(11), 1329-1342 (2011).
146. Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J. Nutr. 137(1 Suppl.), 223S-228S (2007).
147. Fang MZ, Chen D, Sun Y, Jin Z, Christman JK, Yang CS. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res. 11(19 Pt 1), 7033-7041 (2005).
148. Yang CS, Fang M, Lambert JD, Yan P, Huang TH. Reversal of hypermethylation and reactivation of genes by dietary polyphenolic compounds. Nutr. Rev. 66(Suppl 1), S18-S20 (2008).
149. Xiang N, Zhao R, Song G, Zhong W. Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. Carcinogenesis 29(11), 2175-2181 (2008).
150. Lane M, Mcpherson NO, Fullston T et al. Oxidative stress in mouse sperm impairs embryo development, fetal growth and alters adiposity and glucose regulation in female offspring. PLoS ONE 9(7), e100832 (2014).
151. Strakovsky RS, Pan YX. In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases. Antioxid. Redox Signal 17(2), 237-253 (2012).